US 2009/0156606 A1 · OPTICAL CORRECTION

Abstract

The present disclosure describes compositions which improve visual acuity and to methods for their use.

Dependent claims

A medicament for topical administration to an eye comprising:

a first active agent comprising a parasympathetic agonist, and
a second active agent selected from the group consisting of a sympathetic antagonist, a sympathetic agonist and combinations thereof.

Dependencies are inferred from the claim text.

Facts

Application

12/334,916Filed 15 Dec 2008

Priority

GB 0724558.215 Dec 2007

Published

18 Jun 2009

Term ends

Not estimatedThe source records don’t support an estimate.

A61K 31/496
Having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines: non-condensed piperazines…
A61K 9/0048
Galenical forms characterised by the site of application: eye, e.g. artificial tears
A61K 31/138
Having aromatic rings , e.g. ketamine, nortriptyline: aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
A61K 31/216
Of carboxylic acids: of acids having aromatic rings, e.g. benactizyne, clofibrate

The present disclosure describes compositions which improve visual acuity and to methods for their use.

Dependent claims

A medicament for topical administration to an eye comprising:

a first active agent comprising a parasympathetic agonist, and
a second active agent selected from the group consisting of a sympathetic antagonist, a sympathetic agonist and combinations thereof.

Dependencies are inferred from the claim text.